[144] Sera Prognostics, Inc. SEC Filing
Rhea-AI Filing Summary
Sera Prognostics filed a Form 144 reporting a proposed sale under Rule 144 of 8,571 shares of Class A common stock that were acquired through restricted stock unit vesting on 08/08/2025, with an aggregate market value reported at $21,773. The filing lists 38,061,868 shares outstanding and indicates the transaction would be executed through Morgan Stanley Smith Barney LLC on NASDAQ. The same individual, Zhenya Lindgardt, sold 9,406 shares on 05/08/2025, 23,042 on 06/09/2025 and 3,344 on 06/10/2025, producing reported gross proceeds of $22,974, $33,042 and $4,964 respectively. The filer certifies they are not aware of any undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider proposes to sell 8,571 RSU shares; recent sales total 35,792 shares, both amounts are small relative to the 38.06M shares outstanding.
The filing shows the proposed sale of 8,571 shares arising from RSU vesting and prior sales of 35,792 shares in the past three months. Those quantities represent approximately 0.0225% and 0.094% of the reported 38,061,868 shares outstanding, respectively, suggesting limited direct dilution or market impact from these transactions. The use of a major broker and explicit Rule 144 reporting indicate procedural compliance rather than an extraordinary event.
TL;DR: Transactions appear to be routine RSU vesting and secondary sales with the filer attesting no material nonpublic information.
The document identifies the source of the proposed sale as restricted stock unit vesting and lists prior sales by the same person, while including the standard attestation regarding material information and a trading-plan notice. From a governance perspective, the filing meets disclosure expectations under Rule 144 and signals transparency around insider monetization; the record does not disclose any governance or compliance red flags.